Gyre Therapeutics, Inc. GYRE Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Gyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Gyre Therapeutics, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Gyre Therapeutics, Inc.'s operating margin?
- Gyre Therapeutics, Inc. (GYRE) reported operating margin of -0.1% in Q1 2026.
- How has Gyre Therapeutics, Inc.'s operating margin changed year-over-year?
- Gyre Therapeutics, Inc.'s operating margin decreased by 101.2% year-over-year, from 10.3% to -0.1%.
- What is the long-term trend for Gyre Therapeutics, Inc.'s operating margin?
- Over 4 years (2020 to 2025), Gyre Therapeutics, Inc.'s operating margin has grown at a -56.4% compound annual growth rate (CAGR), from -273.9% to 9.9%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.